BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 10052372)

  • 21. Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.
    Silvanose CD; Bailey TA; Di Somma A
    Vet Rec; 2006 Aug; 159(9):282-4. PubMed ID: 16946311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antifungal susceptibility testing of commensal and pathogenic clinical isolates of oral Candida].
    Zhao M; Zhou ZT
    Shanghai Kou Qiang Yi Xue; 2006 Apr; 15(2):218-20. PubMed ID: 16685371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
    Ullmann AJ; Aguado JM; Arikan-Akdagli S; Denning DW; Groll AH; Lagrou K; Lass-Flörl C; Lewis RE; Munoz P; Verweij PE; Warris A; Ader F; Akova M; Arendrup MC; Barnes RA; Beigelman-Aubry C; Blot S; Bouza E; Brüggemann RJM; Buchheidt D; Cadranel J; Castagnola E; Chakrabarti A; Cuenca-Estrella M; Dimopoulos G; Fortun J; Gangneux JP; Garbino J; Heinz WJ; Herbrecht R; Heussel CP; Kibbler CC; Klimko N; Kullberg BJ; Lange C; Lehrnbecher T; Löffler J; Lortholary O; Maertens J; Marchetti O; Meis JF; Pagano L; Ribaud P; Richardson M; Roilides E; Ruhnke M; Sanguinetti M; Sheppard DC; Sinkó J; Skiada A; Vehreschild MJGT; Viscoli C; Cornely OA
    Clin Microbiol Infect; 2018 May; 24 Suppl 1():e1-e38. PubMed ID: 29544767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Itraconazole--perspectives for the management of invasive aspergillosis.
    Groll AH
    Mycoses; 2002; 45 Suppl 3():48-55. PubMed ID: 12690972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species.
    Misra R; Malik A; Singhal S
    Indian J Pathol Microbiol; 2011; 54(1):112-6. PubMed ID: 21393890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Itraconazole in neutropenic patients.
    van't Wout JW
    Chemotherapy; 1992; 38 Suppl 1():23-6. PubMed ID: 1319311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro susceptibility of Trichosporon beigelii to antifungal agents.
    Perparim K; Nagai H; Hashimoto A; Goto Y; Tashiro T; Nasu M
    J Chemother; 1996 Dec; 8(6):445-8. PubMed ID: 8981185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
    Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro susceptibility testing of Candida isolates from clinical specimens to four antifungal agents.
    Ohkawa M; Tokunaga S; Takashima M; Nishikawa T; Hisazumi H; Fujita S; Wheat RW
    Chemotherapy; 1990; 36(6):396-402. PubMed ID: 2292203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland.
    Voelter-Ratson K; Monod M; Unger L; Spiess BM; Pot SA
    Vet Ophthalmol; 2014 Jul; 17 Suppl 1():31-6. PubMed ID: 23910390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro susceptibility to antifungal agents of environmental Cryptococcus spp. isolated in the city of Ribeirão Preto, São Paulo, Brazil.
    Pedroso RS; Ferreira JC; Candido RC
    Mem Inst Oswaldo Cruz; 2006 May; 101(3):239-43. PubMed ID: 16862315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW; Johnson EM; Rogers TR
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of amphotericin B and azoles alone and in combination against disseminated trichosporonosis in neutropenic mice.
    Kamberi P; Atsuro H; Takayoshi T; Masaru N
    Chemotherapy; 1998; 44(1):55-62. PubMed ID: 9444410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit.
    Longman LP; Martin MV
    J Antimicrob Chemother; 1987 Nov; 20(5):719-24. PubMed ID: 2828301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
    Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.